Academy of Managed Care Pharmacy (AMCP) issued the following statement from AMCP CEO Susan A. Cantrell, RPh, CAE about the passing of Brian Thompson, UnitedHealthcare CEO.
On December 4, 2024, the Centers for Medicare and Medicaid Services (CMS) announced that two drug manufacturers of gene therapies for sickle cell disease have entered into agreements to participate in the Cell and Gene Therapy Access Model (CGT Access Model).
Our Associate Vice President of Congressional Affairs Adam Colborn unpacks the key issues the health policy community should be on watch for when preparing for the incoming presidential administration in a recent article for First Report Managed Care.
AMCP Publishes 2024 Election Impacts Deck. Following the Nov. 5 general election, AMCP published a deck highlighting the election results and their expected impact on health policy nationwide.
The United States Pharmacopeia Convention (USP) and the United States Food and Drug Administration (FDA) have updated an educational resource on biosimilars to help healthcare practitioners improve patient confidence in the quality and effectiveness of these treatment options. The following are recommended social media, website, and email content you can use to share this resource with your network.
On November 21, the New York Department of Financial Services (DFS) announced sweeping
market conduct regulations for pharmacy benefit managers (PBMs) serving health plans in the state. The DFS rule implements a landmark 2021 bill, S. 3762/A. 1396, which imposed restrictions on PBM contracts with health plans and pharmacies and established consumer
protections. This action follows previous DFS rulemaking that created a broad definition of
pharmacy benefit management services, required PBMs operating in the state to obtain a license, and established annual reporting requirements.
Missed our live information session about AMCP's Executive Fellowship for 2025-2026 or want to rewatch it? View the session below featuring past and current AMCP Executive Fellows as they share their unique experiences throughout their fellowship and highlight how the program helped them achieve their career goals as pharmacists.
View our Market Insights webinar to explore the latest practice recommendations in the management and treatment of food allergies.
In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.
On November 15, 2024, the Centers for Medicare & Medicaid Services (CMS) issued an update to the set of frequently asked questions (FAQs) related to the Medicare Prescription Payment Plan originally issued on October 1, 2024.
